HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

53.900

+0.9001.70%

Volume:17.01M

Turnover:908.45M

Market Cap:31.42B

PE:-12.03

High:55.000

Open:54.350

Low:51.950

Close:53.000

52wk High:80.900

52wk Low:29.980

Shares:583.00M

HK Float Shares:583.00M

Volume Ratio:1.06

T/O Rate:2.92%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.480

ROE:--

ROA:-1.36%

PB:7.33

PE(LYR):-12.03

PS:29.67

Loading ...

Overview Company News Filings

INSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million

Bulletin Express

Insilico Medicine Nominates Ism9077 as Preclinical Candidate for Ocular Diseases

InSilico Medicine (SEHK:3696) Lands FDA Fast Track And Launches AI Drug Benchmarks

Simply Wall St.

Movement Alert｜INSILICO Falls 5.78% in Regular Trading, Sector-Wide Weakness Overshadows New IND Approval

Insilico Medicine Receives NMPA Approval for Clinical Trial of NLRP3 Inhibitor ISM8969/HT-001 for Parkinson's Disease

Insilico Medicine Wins China NMPA IND Approval for Parkinson’s Drug Ism8969/ht-001

Insilico Medicine Cayman Topco - Receives Nmpa Ind Approval for ISM8969/Ht-001

THOMSON REUTERS

Movement Alert｜INSILICO Rises 5.09% in Regular Trading, ISM6331 Granted FDA Fast Track Designation Plus Sector Recovery

Movement Alert｜INSILICO Falls 5.52% in Regular Trading, Trading at HK$40.94

Insilico Medicine Receives FDA Fast Track Designation for Ism6331, the Ai-Driven Pan-Tead Inhibitor, in Advanced Mesothelioma

Insilico Medicine's Pleural Mesothelioma Drug Receives US FDA Fast Track Designation; Shares Down 4%

MT Newswires Live

Movement Alert｜INSILICO Falls 5.31% in Regular Trading, ISM6331 Receives FDA Fast Track Designation But Selling Pressure Persists

INSILICO (03696): ISM6331 Receives FDA Fast Track Designation for Advanced Mesothelioma Treatment

Insilico Medicine Cayman Topco - Receives FDA Fast Track Designation for Ism6331 in Advanced Mesothelioma

THOMSON REUTERS

Movement Alert｜INSILICO Falls 5.07% in Regular Trading, Trading at 45.2 HKD

Insilico Medicine Announces Oral Presentation at Esmo 2026 for Phase 1 Clinical Study of Ism6331 in Mesothelioma and Advanced Solid Tumors

THOMSON REUTERS

INSILICO to Present First-in-Human Phase I Data for AI-Designed Pan-TEAD Inhibitor ISM6331 at ESMO 2026

Bulletin Express

Insilico Medicine Says Ism6331 Phase I Data in Mesothelioma, Advanced Solid Tumors Accepted for ESMO 2026 Rapid Oral Presentation

Beijing's Token Economy Push and Battery Tax Shifts Reshape Market Dynamics

INSILICO Shares Surge Over 7% Again Following Keynote at AI Conference and Major Partnership Announcements

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/03696/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":53.9,"timestamp":1789027724005,"preClose":53,"halted":0,"volume":17013805,"delay":0,"changeRate":0.01698113207547167,"floatShares":583000000,"shares":583000000,"eps":-4.48,"marketStatus":"Closed","change":0.9,"latestTime":"09-10 16:08:44","open":54.35,"high":55,"low":51.95,"amount":908453357,"amplitude":0.057547,"askPrice":53.95,"askSize":2000,"bidPrice":53.9,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-4.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":53,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.06069,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":583000000,"roa":"-1.36%","roe":"--","lyrEps":-4.48,"volumeRatio":1.06069,"shares":583000000,"dividePrice":0,"high":55,"amplitude":0.057547,"preClose":53,"low":51.95,"week52Low":29.98,"pbRate":"7.33","psRate":"29.67","week52High":80.9,"institutionHeld":0,"latestPrice":53.9,"committee":0.428571,"eps":-4.48,"divideRate":0,"volume":17013805,"delay":0,"ttmEps":-4.006,"open":54.35,"prevYearClose":37.14,"prevWeekClose":48.76,"prevMonthClose":43.74,"prevQuarterClose":39.62,"fiveDayClose":47,"twentyDayClose":46.38,"sixtyDayClose":32.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786032000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-09-09","current":-13.354968,"percent":0.435294,"low":-126.474328,"twenty":-93.127559,"median":-12.517861,"eighty":-8.791356,"high":-6.819055,"avg":-40.471792,"sd":41.550192,"marketCap":30519413046},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800},{"date":"2026-05-29","current":-8.622113,"twenty":-102.242154,"median":-83.671368,"eighty":-12.624497,"marketCap":23800475160},{"date":"2026-06-05","current":-7.875348,"twenty":-101.790811,"median":-78.255166,"eighty":-12.515704,"marketCap":21739827960},{"date":"2026-06-12","current":-7.01543,"twenty":-100.06892,"median":-65.190557,"eighty":-12.085532,"marketCap":19370083680},{"date":"2026-06-18","current":-7.947724,"twenty":-100.046598,"median":-60.518922,"eighty":-10.958896,"marketCap":21945892680},{"date":"2026-06-26","current":-7.919554,"twenty":-99.340788,"median":-54.070713,"eighty":-10.005367,"marketCap":21877204440},{"date":"2026-07-03","current":-7.743582,"twenty":-98.690073,"median":-27.191152,"eighty":-9.565807,"marketCap":21396386760},{"date":"2026-07-10","current":-8.877372,"twenty":-98.062553,"median":-14.676127,"eighty":-8.824583,"marketCap":24510253640},{"date":"2026-07-17","current":-8.953114,"twenty":-97.4013,"median":-14.167396,"eighty":-8.882012,"marketCap":24727766400},{"date":"2026-07-24","current":-9.751189,"twenty":-96.617922,"median":-13.560542,"eighty":-8.925911,"marketCap":26937238120},{"date":"2026-07-31","current":-9.466525,"twenty":-95.411086,"median":-13.340785,"eighty":-8.88656,"marketCap":26158771400},{"date":"2026-08-07","current":-9.410567,"twenty":-94.035578,"median":-13.201047,"eighty":-8.763781,"marketCap":26009946880},{"date":"2026-08-14","current":-9.225945,"twenty":-93.733176,"median":-12.895614,"eighty":-8.825762,"marketCap":25506233120},{"date":"2026-08-21","current":-8.414722,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"marketCap":23250969240},{"date":"2026-08-28","current":-11.42993,"twenty":-93.240519,"median":-12.603589,"eighty":-8.725669,"marketCap":26661298566},{"date":"2026-09-04","current":-12.035257,"twenty":-93.142096,"median":-12.516782,"eighty":-8.763781,"marketCap":28077860002},{"date":"2026-09-09","current":-13.078998,"twenty":-93.127559,"median":-12.517861,"eighty":-8.791356,"marketCap":30519413046}],"updateTime":1789027304168},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134662320","title":"INSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1134662320","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134662320?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:26","pubTimestamp":1786008391,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives. Key figures   • Authorised share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657577222","title":"Insilico Medicine Nominates Ism9077 as Preclinical Candidate for Ocular Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2657577222","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657577222?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:30","pubTimestamp":1785976220,"startTime":"0","endTime":"0","summary":"Insilico Medicine nominates ISM9077 as preclinical candidate for ocular diseasesInsilico Medicine Cayman Topco nominated ISM9077, a potential first-in-class Target Y inhibitor, as a preclinical candid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3NbpZl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558253","title":"InSilico Medicine (SEHK:3696) Lands FDA Fast Track And Launches AI Drug Benchmarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558253","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558253?lang=en_us&edition=fundamental","pubTime":"2026-08-04 11:28","pubTimestamp":1785814137,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (SEHK:3696) received FDA Fast Track Designation for ISM6331, an AI-generated pan-TEAD inhibitor for malignant pleural mesothelioma.\nThe company secured NMPA IND approval for ISM8969/HT-001, a BBB-penetrant NLRP3 inhibitor for neuroinflammatory diseases such as Parkinson's, enabling parallel trials in China and Australia.\nInSilico Medicine Cayman TopCo launched a Drug Discovery and Development Benchmarks as a Service platform to measure AI and foundation model...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-sehk3696-lands-fda-fast-track-and-launches","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-sehk3696-lands-fda-fast-track-and-launches","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","ARTY","BK4588","CHAT","VTHR","AIPO","LABU","QTOC","AGIX","03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120232971","title":"Movement Alert｜INSILICO Falls 5.78% in Regular Trading, Sector-Wide Weakness Overshadows New IND Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1120232971","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120232971?lang=en_us&edition=fundamental","pubTime":"2026-08-03 13:26","pubTimestamp":1785734806,"startTime":"0","endTime":"0","summary":"On August 3, INSILICO fell 5.78% in regular trading, trading at 43.06 HKD/share, with turnover of approximately 517 million HKD. The decline came despite the company announcing on the same day that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192196095","title":"Insilico Medicine Receives NMPA Approval for Clinical Trial of NLRP3 Inhibitor ISM8969/HT-001 for Parkinson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=1192196095","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192196095?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:28","pubTimestamp":1785716913,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696.HK) has announced that its novel oral NLRP3 inhibitor, ISM8969/HT-001, co-developed with Shenzhen 衡泰生物科技有限公司 (Hengtai Biotech), has received clinical trial approval from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","MDTX","03696","BK4218","IBBJ","HT","IBBQ","BMED","01611","BK1167","BK1612","PSYK","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656709346","title":"Insilico Medicine Wins China NMPA IND Approval for Parkinson’s Drug Ism8969/ht-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2656709346","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656709346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:15","pubTimestamp":1785716149,"startTime":"0","endTime":"0","summary":"Insilico Medicine wins China NMPA IND approval for Parkinson’s drug ISM8969/HT-001Insilico Medicine received China NMPA IND clearance for ISM8969/HT-001, an oral blood-brain-barrier-penetrant NLRP3 in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL1kmsFJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656467703","title":"Insilico Medicine Cayman Topco - Receives Nmpa Ind Approval for ISM8969/Ht-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2656467703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656467703?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:15","pubTimestamp":1785716139,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145899210","title":"Movement Alert｜INSILICO Rises 5.09% in Regular Trading, ISM6331 Granted FDA Fast Track Designation Plus Sector Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1145899210","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145899210?lang=en_us&edition=fundamental","pubTime":"2026-07-31 09:33","pubTimestamp":1785461603,"startTime":"0","endTime":"0","summary":"On July 31, INSILICO rose 5.09% in regular trading, trading at 44.52 HKD/share, with turnover of 43.21 million HKD. The stock rebounded after a cumulative decline of approximately 9% over the prior...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INSILICO Rises; ISM6331 Granted FDA Fast Track Designation Plus Sector Recovery","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159094499","title":"Movement Alert｜INSILICO Falls 5.52% in Regular Trading, Trading at HK$40.94","url":"https://stock-news.laohu8.com/highlight/detail?id=1159094499","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159094499?lang=en_us&edition=fundamental","pubTime":"2026-07-30 11:23","pubTimestamp":1785381801,"startTime":"0","endTime":"0","summary":"On July 30, INSILICO fell 5.52% in regular trading, trading at HK$40.94/share, with turnover of HK$218 million.Within the Life Sciences Tools & Services sector where INSILICO belongs, the overall...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655898806","title":"Insilico Medicine Receives FDA Fast Track Designation for Ism6331, the Ai-Driven Pan-Tead Inhibitor, in Advanced Mesothelioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2655898806","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655898806?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:31","pubTimestamp":1785328314,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Receives FDA Fast Track Designation For Ism6331, The Ai-Driven Pan-Tead Inhibitor, In Advanced MesotheliomaJuly 29 (Reuters)-Insilico Medicine Cayman TopCo3696.HK:INSILICO MEDI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA213NP5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655518988","title":"Insilico Medicine's Pleural Mesothelioma Drug Receives US FDA Fast Track Designation; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655518988","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655518988?lang=en_us&edition=fundamental","pubTime":"2026-07-29 14:16","pubTimestamp":1785305797,"startTime":"0","endTime":"0","summary":"Insilico Medicine (HKG:3696) said ISM6331 received fast-track designation from the U.S. Food and Drug Administration for the treatment of adult patients with unresectable malignant pleural mesotheliom","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585","BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145686882","title":"Movement Alert｜INSILICO Falls 5.31% in Regular Trading, ISM6331 Receives FDA Fast Track Designation But Selling Pressure Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=1145686882","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145686882?lang=en_us&edition=fundamental","pubTime":"2026-07-29 10:21","pubTimestamp":1785291699,"startTime":"0","endTime":"0","summary":"On July 29, INSILICO fell 5.31% in regular trading, trading at 40.58 HKD/share, with turnover of HKD 183 million. The decline extends a multi-day selloff, following a 5.07% drop on July 28.On the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"INSILICO Falls; ISM6331 Receives FDA Fast Track Designation But Selling Pressure Persists","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109668431","title":"INSILICO (03696): ISM6331 Receives FDA Fast Track Designation for Advanced Mesothelioma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1109668431","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109668431?lang=en_us&edition=fundamental","pubTime":"2026-07-29 08:24","pubTimestamp":1785284658,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its AI-driven, potentially best-in-class pan-TEAD inhibitor, ISM6331, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK4588","BK4585","BK1141","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655842831","title":"Insilico Medicine Cayman Topco - Receives FDA Fast Track Designation for Ism6331 in Advanced Mesothelioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2655842831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655842831?lang=en_us&edition=fundamental","pubTime":"2026-07-29 08:15","pubTimestamp":1785284128,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43U1D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102489424","title":"Movement Alert｜INSILICO Falls 5.07% in Regular Trading, Trading at 45.2 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1102489424","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102489424?lang=en_us&edition=fundamental","pubTime":"2026-07-28 10:07","pubTimestamp":1785204423,"startTime":"0","endTime":"0","summary":"On July 28, INSILICO fell 5.07% in regular trading, trading at 45.2 HKD/share, with Turnover of 101 million HKD.Within the Life Sciences Tools & Services sector where INSILICO belongs, the overall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2654175390","title":"Insilico Medicine Announces Oral Presentation at Esmo 2026 for Phase 1 Clinical Study of Ism6331 in Mesothelioma and Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2654175390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654175390?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA9BRRL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114236077","title":"INSILICO to Present First-in-Human Phase I Data for AI-Designed Pan-TEAD Inhibitor ISM6331 at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1114236077","media":"Bulletin Express","labels":["productRelease","conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114236077?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:23","pubTimestamp":1785111827,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) has announced that Phase I clinical data for its novel pan-TEAD inhibitor, ISM6331, have been selected for a Rapid Oral presentation at the European Society...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060728","title":"Insilico Medicine Says Ism6331 Phase I Data in Mesothelioma, Advanced Solid Tumors Accepted for ESMO 2026 Rapid Oral Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060728","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060728?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:15","pubTimestamp":1785111359,"startTime":"0","endTime":"0","summary":"Insilico Medicine says ISM6331 Phase I data in mesothelioma, advanced solid tumors accepted for ESMO 2026 rapid oral presentationInsilico Medicine flagged first-in-human Phase I data for ISM6331, an A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL4xZpBj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195647185","title":"Beijing's Token Economy Push and Battery Tax Shifts Reshape Market Dynamics","url":"https://stock-news.laohu8.com/highlight/detail?id=1195647185","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195647185?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:34","pubTimestamp":1784810098,"startTime":"0","endTime":"0","summary":"Hong Kong stocks displayed resilience today, with the Hang Seng Index advancing 1.28%. Despite a pullback in the tech sector, major heavyweights provided stability to the broader market.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823040885.USD","LU0084288322.USD","LU0979878070.USD","LU0231483743.USD","LU1831875114.USD","LU0593848301.USD","LU0047713382.USD","LU0868486357.SGD","LU0588545490.SGD","LU1048588211.SGD","LU0348827113.USD","01378","LU0149721374.USD","IE00B5MMRT66.SGD","LU0499858438.USD","LU0052750758.USD","LU0865486749.SGD","LU1102505929.USD","LU0164880469.USD","LU0011963245.USD","LU1166156734.SGD","LU1188198961.HKD","LU0348805143.USD","BK1500","LU1242518931.SGD","LU2152927971.USD","SG9999002562.SGD","LU0683595622.HKD","IE00BF5LJ272.USD","IE0032431581.USD","LU0106252389.USD","LU0211977185.USD","LU0326950275.SGD","LU0572939691.SGD","IE0034224299.USD","LU0588545904.SGD","LU0737861699.HKD","LU0797268264.HKD","LU0873338254.USD","LU1152091754.HKD","LU0039217434.USD","IE00B543WZ88.USD","LU0054450605.USD","LU0345781412.USD","LU0561508036.HKD","LU0594300419.USD","LU0611395673.USD","LU1282648689.USD","LU0594300179.USD","IE00B3M56506.USD","LU0918141887.USD","BK1155","159796","LU1770034418.SGD","LU0132412106.USD","IE00B0JY6N72.USD","LU1993786604.SGD","IE00BPRC5H50.USD","LU1323998911.USD","LU0634319403.HKD","LU2242644610.SGD","LU0164872284.USD","LU0348788117.USD","KCAI","LU0502904849.HKD","LU0165289439.USD","LU0823041008.USD","LU1960683339.HKD","LU0455707207.USD","BK4585","LU0878005551.USD","LU0469268626.HKD","LU0577902611.USD","LU0143863784.USD","LU0251144936.SGD","LU1880383366.USD","LU1808992512.USD","LU0320764599.SGD","LU2476274308.USD","LU0359201612.USD","03317","LU1675838814.USD","BK1592","LU0214875030.USD","LU2097828714.EUR","SG9999014674.SGD","BK1604","HK0001040143.USD","LU0509642566.USD","LU2476274720.SGD","LU2148510915.USD","LU0029875118.USD","LU2257852520.SGD","03696","IE00B29SXG58.USD","LU0449515922.USD","SG9999001689.USD","SG9999002828.SGD","LU0370786039.SGD","LU0348825331.USD","BK1255","BK1594","LU0577902298.EUR","LU0577902538.SGD","LU0819121731.USD","LU0918141705.HKD","BK1610","LU1152091168.USD","LU0588545730.USD","LU0431992006.USD","LU0819123356.HKD","LU0417516902.SGD","LU0307460666.USD","LU0128522157.USD","LU0117841782.USD","LU0359202008.SGD","LU0072913022.USD","LU0577902371.SGD","LU0359201885.HKD","LU0577902454.USD","LU2045819591.USD","LU0287142896.SGD","LU0326948709.USD","LU0630314457.HKD","BK1618","LU0572940350.SGD","LU0540923850.HKD","LU1688375341.USD","BK1172","SG9999001093.SGD","LU0345775950.USD","LU0856984785.SGD","LU0173614495.USD","LU0871576103.HKD","LU1880383440.USD","LU0828238088.HKD","LU0345776255.USD","LU0269904917.USD","LU0051755006.USD","LU1242518857.USD","SG9999001903.USD","LU1023057109.AUD","LU0264606111.USD","BK1233","BK1175","LU0456827905.SGD","LU0672654166.SGD","LU0633140560.USD","LU0228659784.USD","LU0541501648.USD","LU0708995583.HKD","LU1226287529.USD","LU1251922891.USD","MPNGY","IE0008369823.USD","LU2125910500.SGD","LU0463099449.HKD","BK1583","LU1048596156.SGD","IE00B031HY20.USD","LU1064131003.USD","LU1720050803.USD","LU1328277881.USD","LU2087589342.USD","LU0541502299.USD","BK1589","BK1615","LU0823426308.USD","LU1008478684.HKD","LU0143863198.USD","LU0531971595.HKD","LU0067412154.USD","LU2226246903.HKD","LU2039709279.SGD","LU1102505762.USD","LU1481107354.HKD","BK1142","LU0572944931.SGD","LU1770036033.HKD","SG9999002463.SGD","LU0043850808.USD","LU2488822045.USD","LU0456846285.SGD","HMTD.SI","LU2097828474.EUR","BK1591","IE0008368742.USD","LU1734074674.USD","LU0348816934.USD","LU0633140727.USD","03690","LU0327786744.USD","LU0880133367.SGD","LU0700851271.USD","LU0501845795.SGD","LU1105468828.SGD","LU0314109678.HKD","LU0054237671.USD","LU0702159699.USD","SG9999000459.SGD","LU0140636845.USD","BK4588","LU0244354667.USD","BK1521","LU0315178854.USD","LU0072462343.USD","LU1868837722.USD","LU0823038988.USD","BK1141","LU0345780950.USD","LU0348735423.USD","LU1813983027.USD","LU1961090484.USD","LU0261950983.USD","SG9999000327.SGD","LU2097828557.USD","LU1064130708.USD","LU1868837565.USD","LU1224709979.USD","LU0589944569.HKD","VXUS","LU0823426480.USD","LU0048580855.USD","LU0650527681.SGD","LU0417516738.SGD","KWEB","LU1719994722.HKD","LU0828237940.HKD","BK1575","LU0823039010.USD","02643","LU0828237510.HKD","02282","LU0499858602.USD","LU2097828805.USD","LU0049853897.USD","LU0449509016.USD","LU0181495838.USD","LU0210526637.USD","LU0821914370.USD","LU1807302812.USD","LU0348814723.USD","LU2097828631.EUR","LU0196878994.USD","METmain","LU0048597586.USD","LU0605514214.HKD","LU1303224171.USD","LU0543330483.HKD","LU1328615791.USD","HK0001040168.HKD","LU2778985437.USD","LU1794554557.SGD","LU0320764755.SGD","LU0164865239.USD","LU0588546209.SGD","LU2399975544.HKD","LU1868838027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132217460","title":"INSILICO Shares Surge Over 7% Again Following Keynote at AI Conference and Major Partnership Announcements","url":"https://stock-news.laohu8.com/highlight/detail?id=1132217460","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132217460?lang=en_us&edition=fundamental","pubTime":"2026-07-23 14:00","pubTimestamp":1784786428,"startTime":"0","endTime":"0","summary":"Shares of INSILICO (03696) surged more than 7% during the trading session. At the time of writing, the stock was up 5.85% to HK$48.1, with a turnover of HK$477 million.The price movement follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK1141","03696","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}